新型移动健康应用程序:为老年癌症患者提供老年评估驱动的干预措施卡塔尔世界杯8强波胆分析试点可行性和可用性研究% Loh, Kah Poh % Ramsdale,埃里卡% Culakova,伊娃%孟德尔,杰森H % Liesveld,简L % 'Dwyer阿,克里斯汀M %麦克休,科林% Gilles,马克森斯%劳埃德,特里%古德曼,莫莉% Klepin,海蒂D %马斯蒂安,Karen M % Schnall,丽贝卡% Mohile, Supriya G % +分工血液学/肿瘤学,詹姆斯P威尔莫特癌症研究所,罗切斯特大学医学中心,榆木大街601号,704箱,罗切斯特,纽约,14642年,美国,1 4133069767,kahpoh_loh@urmc.rochester.edu %K移动健康应用%K老年评估%K老年人%K癌症%D 2018 %7 29.10.2018 %9原文%J JMIR癌症%G英文%X背景:老年癌症患者不良结局风险增加。老年评估(GA)是一套可靠且经过验证的工具汇编，用于评估作为发病率和死亡率预测因素的领域，并可用于指导干预措施。然而，由于资源和时间的限制，遗传算法和遗传算法驱动的干预措施的实施很少。通过移动应用程序提供的ga驱动干预可能支持老年癌症患者及其护理人员的复杂需求。目的:我们旨在评估一种新型应用程序(TouchStream)的可行性和可用性，并确定其使用的障碍。作为探索目的，我们收集了症状负担、医疗保健利用和满意度的初步数据。方法:在一项单点试点研究中，我们纳入了年龄≥65岁接受系统性癌症治疗的患者及其护理人员。TouchStream由一个移动应用程序和一个Web门户组成。 Patients underwent a GA at baseline with the study team (on paper), and the results were used to guide interventions delivered through the app. A tablet preloaded with the app was provided for use at home for 4 weeks. Feasibility metrics included usability (system usability scale of >68 is considered above average), recruitment, retention (number of subjects consented who completed postintervention assessments), and percentage of days subjects used the app. For the last 8 patients, we assessed their symptom burden (severity and interference with 17-items scored from 0-10 where a higher score indicates worse symptoms) using a clinical symptom inventory, health care utilization from the electronic medical records, and satisfaction (6 items scored on a 5-point Likert Scale for both patients and caregivers where a higher score indicates higher satisfaction) using a modified satisfaction survey. Barriers to use were elicited through interviews. Results: A total of 18 patients (mean age 76.8, range 68-87) and 13 caregivers (mean age 69.8, range 38-81) completed the baseline assessment. Recruitment and retention rates were 67% and 80%, respectively. The mean SUS score was 74.0 for patients and 72.2 for caregivers. Mean percentage of days the TouchStream app was used was 78.7%. Mean symptom severity and interference scores were 1.6 and 2.8 at preintervention, and 0.9 and 1.5 at postintervention, respectively. There was a total of 27 clinic calls during the intervention period and 15 during the postintervention period (week 5-8). One patient was hospitalized during the intervention period (week 1-4) and two patients during the postintervention period (week 5-8). Mean satisfaction scores of patients and caregivers with the mobile app were 20.4 and 23.4, respectively. Barriers fell into 3 themes: general experience, design, and functionality. Conclusions: TouchStream is feasible and usable for older patients on cancer treatment and their caregivers. Future studies should evaluate the effects of the TouchStream on symptoms and health care utilization in a randomized fashion. %M 30373733 %R 10.2196/10296 %U http://cancer.www.mybigtv.com/2018/2/e10296/ %U https://doi.org/10.2196/10296 %U http://www.ncbi.nlm.nih.gov/pubmed/30373733